Rice’s new Synthesis X Center has winning formula for cancer innovation
Rice has created the new Synthesis X Center to bring together clinicians treating cancer and researchers looking for cures to help spur drug discovery make precision adjustments to drug properties and translate fundamental research discoveries into clinical applications.
Rice engineer Jacob Robinson participated in the first “Houston Day: Beyond the Bayou” program organized by the Greater Houston Partnership, which brought together state legislators from across Texas for a two-day legislative advocacy event in Houston earlier this month.
Rice study unlocks breakthrough for breast cancer bone metastases
Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients.
Rice’s Medical Humanities Research Institute has transformational agenda for health care
Rice University has launched its Medical Humanities Research Institute, the only institute in the United States and one of few in the world solely dedicated to advancing translational research on human experiences of health and illness.
Feds fund $45M Rice-led research that could slash US cancer deaths by 50%
The Advanced Research Projects Agency for Health has awarded a Rice-led team $45 million to rapidly develop an implant with sense-and-respond technology that could slash U.S. cancer-related deaths by more than 50%.
Rice University today introduced the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
Rice researchers earn prestigious Defense Department grants
Rice professors Qimiao Si and Jeffrey Tabor are recipients of prestigious 2023 Vannevar Bush Faculty Fellowships from the Department of Defense.
DNA test could broaden access to cervical cancer screening
Rice bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more than 300,000 women each year.
Neuroengineering’s InterfaceRice 2023 conference draws 160-plus
More than 160 leaders in neurotechnology, neuroscience, neuroengineering and neurosurgery attended InterfaceRice 2023, the inaugural conference of the Rice Neuroengineering Initiative, May 18-19.
Rice, Baylor developing ‘glyco-immune’ checkpoint inhibitor
Researchers from Rice and Baylor College of Medicine are developing a first-of-its-kind “glyco-immune” checkpoint inhibitor for breast cancer survivors who develop metastatic bone cancer.
Duncan, Spiegel honored at Rice360 awards breakfast
The Rice360 Institute for Global Health Technologies presented its 2023 Global Champion Award to philanthropist Jan Duncan and its 2023 Alumni Leadership Award to physician Elizabeth Spiegel ’11 at its graduate recognition and awards breakfast May 5.
Study unlocks potential breakthrough in Type 1 diabetes treatment
Rice University scientists identified three biomaterial formulations that could help develop a more sustainable, long-term, self-regulating way to treat Type 1 diabetes using a new screening technique that involves tagging each biomaterial formulation in a library of hundreds with a unique “barcode.”
A 21st-century remedy for missed meds
Rice lab’s next-level encapsulation technology for drugs and vaccines could solve a $100 billion problem.
James Chappell wins NSF CAREER Award
Rice bioscientist James Chappell has won a National Science Foundation CAREER Award to develop RNA programming methods that can improve human health and the environment.
Rice labs seek RNA programming for ‘smart’ antibiotics
Rice University synthetic biologists are working to make “genetically encoded antibiotics” that kill only disease-causing bacteria.
